History
  • No items yet
midpage
Zhejiang Medicine Co., Ltd. v. Kaneka Corporation
676 F. App'x 962
| Fed. Cir. | 2017
Read the full case

Background

  • Kaneka sued Zhejiang Medicine Co., Ltd. and ZMC-USA LLC (ZMC) for infringing U.S. Patent No. 7,910,340, which claims a process that includes an "oxidizing" step converting reduced CoQ10 to oxidized CoQ10.
  • The dispute centered on the construction of "oxidizing": whether it requires merely an "active step" causing oxidation (Kaneka's position per prior Federal Circuit guidance) or requires oxidation greater than passive ambient-air oxidation (ZMC and the district court's later interpretation).
  • In a prior Federal Circuit decision (Kingdomway), the court construed "oxidizing" to require "some action resulting in oxidation" and held it need not involve an oxidizing agent.
  • After Kingdomway, the district court interpreted that construction to require oxidation in excess of passive oxidation and excluded portions of Kaneka’s expert Dr. Sherman as irrelevant; it also denied Kaneka leave to supplement.
  • ZMC moved for summary judgment of noninfringement; the district court granted it, finding no evidence that ZMC’s active steps caused oxidation beyond passive levels.
  • The Federal Circuit vacated the grant of summary judgment and remanded: it held the district court misread Kingdomway (active step does not require greater-than-passive oxidation), affirmed exclusion of parts of Dr. Sherman’s report without deciding all relevance issues, and found genuine factual disputes exist based on ZMC process data.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Proper construction of "oxidizing" Kingdomway requires only an "active step" that results in oxidation; no need to show increased oxidation versus passive levels "Oxidizing" must mean oxidation in excess of passive ambient oxidation Court: Kingdomway means "some action resulting in oxidation"; district court erred to require excess over passive oxidation
Exclusion of plaintiff's expert (Dr. Sherman) Sherman's report already addresses activity that causes oxidation under Kingdomway and should remain Sherman's opinions based on pre-Kingdomway construction are irrelevant and should be excluded Court: affirmed exclusion of portions of the report under district court’s (misapplied) reasoning but declined to resolve relevance anew; left supplementation decision to district court on remand
Summary judgment of noninfringement Evidence (ZMC process steps and studies) raises genuine dispute that ZMC’s active washing/drying steps result in oxidation as required No evidence that any oxidation is due to ZMC's active steps rather than passive exposure; thus noninfringement Court: vacated summary judgment — material factual dispute exists whether ZMC's active steps result in oxidation; remanded
Burden/evidence standard for proving "oxidizing" Need only show some action resulted in oxidation; comparative increased rate evidence is persuasive but not required at summary judgment Plaintiff must show oxidation beyond passive baseline; absence of such proof justifies judgment Court: plaintiff need not prove increased oxidation vs passive; focus is whether a reasonable jury could find an active step resulted in oxidation

Key Cases Cited

  • Kaneka Corp. v. Xiamen Kingdomway Grp. Co., 790 F.3d 1298 (Fed. Cir. 2015) ("oxidizing" requires an active step — "some action resulting in oxidation" — and need not use an oxidizing agent)
  • LaserDynamics, Inc. v. Quanta Comput., Inc., 694 F.3d 51 (Fed. Cir. 2012) (standard of review for evidentiary rulings and summary judgment principles in patent appeals)
  • Anderson v. Liberty Lobby, Inc., 477 U.S. 242 (U.S. 1986) (summary judgment requires viewing evidence in the light most favorable to nonmovant; genuine dispute of material fact standard)
Read the full case

Case Details

Case Name: Zhejiang Medicine Co., Ltd. v. Kaneka Corporation
Court Name: Court of Appeals for the Federal Circuit
Date Published: Jan 23, 2017
Citation: 676 F. App'x 962
Docket Number: 2016-1390
Court Abbreviation: Fed. Cir.